Latest Industry Insights
Next-Generation Sequencing: Tracking the Spread and Evolution of SARS-CoV-2
This article explores how next-generation sequencing (NGS) is being used to help track the spread and evolution of SARS-CoV-2, including pinpoint the different lineages of the virus and identifying patterns of its movement both globally as well as locally.
Can You Achieve Rapid MS Analysis With No Sample Prep?
News of how innovations can assist scientists and their workflows is not uncommon, but claims of “industry revolutions”, however, tend to be a little less frequent. The Echo® MS System from SCIEX is touted as being one such revolution, we spoke to Neil Walsh to learn more.
A Smarter Way To Remove Host Cell Protein Contamination From Gene Therapies
In this piece, Ejvind Mørtz and Todd Stawicki explain why it’s critical that gene therapy products are free of host cell proteins and how this can be ensured in the production process, so that these next-generation drugs can fulfil their potential as one-shot cures for a range of diseases, from rare genetic conditions to cancer.
A Conversation With Professor Josef Penninger on the Journey to a COVID-19 Therapeutic
The ACE2 receptor has garnered significant attention for the wrong reasons over recent months. Could it point towards an exit route out of this pandemic? In an interview with Technology Networks, the renowned immunologist Professor Josef Penninger explains why he thinks so, and discusses the latest clinical data obtained from testing the soluble ACE2 receptor, APN01.
How Can Healthcare Workers Keep Up With the Latest Research?
Between caring for patients and battling global pandemics, healthcare workers have a lot on their plate. How can healthcare workers make time to keep abreast of the latest literature in their field?
LAMP-Based Testing for COVID-19
Technology Networks recently spoke to Dr Gary Keating, Chief Technical Officer at Hibergene Diagnostics, to learn more about LAMP technology and the advantages it could offer for COVID-19 testing. Gary also discussed some of the challenges faced when developing diagnostics and how the COVID-19 pandemic has impacted diagnostic design and manufacturing.
COVID-19 Antibody Testing: S vs. N Protein
Technology Networks spoke to Dr Iswariya Venkataraman, Scientific Affairs Lead at EUROIMMUN US, to learn about the differences between the S and N proteins and what makes them suitable as target antigens in serology testing. Iswariya also discussed the findings and implications from a study which cautioned against the extensive use of tests that detect antibodies against the N protein only.
From Vaccine Printers to DNA Data Storage, What's in Store for the Future of Synthetic Biology?
Scientists are harnessing the power of synthetic biology – a field of science that involves redesigning biological components to generate novel synthetic entities – to solve scientific problems and drive innovation in medicine. Technology Networks recently spoke with Codex DNA’s CEO Todd R. Nelson to learn about the impact synthetic biology techniques are having on pharmaceutical development and the "big trends" in synthetic biology we are already seeing and are expected to see in the next few years.
Using Organoids in the Study of Infectious Diseases
By providing greater physiologic relevance and a species- or patient-specific test platform, organoids overcome many limitations of conventional 2D cultures and even live-animal disease models.
Exploring SARS-CoV-2 Antibody Testing
Technology Networks spoke to Jeff Hawkins, Dr Jerry Yeo, and Dr Abhijit Datta, to learn how the information provided by antibody tests can be used appropriately during the COVID-19 pandemic.